These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24399199)

  • 21. Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats.
    Calik MW; Carley DW
    PLoS One; 2014; 9(10):e111412. PubMed ID: 25350456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor.
    Cox ML; Haller VL; Welch SP
    Eur J Pharmacol; 2007 Sep; 570(1-3):50-6. PubMed ID: 17588560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system.
    Kruk-Slomka M; Michalak A; Biala G
    Behav Brain Res; 2015 May; 284():24-36. PubMed ID: 25660201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
    Romero TR; Pacheco Dda F; Duarte ID
    Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors.
    Umathe SN; Manna SS; Utturwar KS; Jain NS
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1191-9. PubMed ID: 19580839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S-777469, a novel cannabinoid type 2 receptor agonist, suppresses itch-associated scratching behavior in rodents through inhibition of itch signal transmission.
    Haruna T; Soga M; Morioka Y; Hikita I; Imura K; Furue Y; Yamamoto M; Imura C; Ikeda M; Yamauchi A; Deguchi M; Shichijo M; Arimura A; Yasui K
    Pharmacology; 2015; 95(1-2):95-103. PubMed ID: 25721168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in peripheral endocannabinoid modulation of scratching behavior in facial vs. spinally-innervated skin.
    Spradley JM; Davoodi A; Gee LB; Carstens MI; Carstens E
    Neuropharmacology; 2012 Sep; 63(4):743-9. PubMed ID: 22683515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Efficacy of Eslicarbazepine Acetate in Models of Trigeminal, Neuropathic, and Visceral Pain: The Involvement of 5-HT1B/1D Serotonergic and CB1/CB2 Cannabinoid Receptors.
    Tomić MA; Pecikoza UB; Micov AM; Stepanović-Petrović RM
    Anesth Analg; 2015 Dec; 121(6):1632-9. PubMed ID: 26465930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action.
    Schlosburg JE; O'Neal ST; Conrad DH; Lichtman AH
    Psychopharmacology (Berl); 2011 Aug; 216(3):323-31. PubMed ID: 21340468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential hepatoprotective role of the cannabinoid CB
    Rivera P; Vargas A; Pastor A; Boronat A; López-Gambero AJ; Sánchez-Marín L; Medina-Vera D; Serrano A; Pavón FJ; de la Torre R; Agirregoitia E; Lucena MI; Rodríguez de Fonseca F; Decara J; Suárez J
    Br J Pharmacol; 2020 Jul; 177(14):3309-3326. PubMed ID: 32167157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis.
    Giannone FA; Baldassarre M; Domenicali M; Zaccherini G; Trevisani F; Bernardi M; Caraceni P
    Lab Invest; 2012 Mar; 92(3):384-95. PubMed ID: 22184091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents.
    Croci T; Landi M; Galzin AM; Marini P
    Br J Pharmacol; 2003 Sep; 140(1):115-22. PubMed ID: 12967941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover.
    Darmani NA; Janoyan JJ; Kumar N; Crim JL
    Pharmacol Biochem Behav; 2003 Jul; 75(4):777-87. PubMed ID: 12957219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Descending serotonergic and noradrenergic systems do not regulate the antipruritic effects of cannabinoids.
    Todurga ZG; Gunduz O; Karadag CH; Ulugol A
    Acta Neuropsychiatr; 2016 Dec; 28(6):321-326. PubMed ID: 27805543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurokinin-1 receptor antagonist orvepitant is an effective inhibitor of itch-associated response in a Mongolian gerbil model of scratching behaviour.
    Trower MK; Fisher A; Upton N; Ratti E
    Exp Dermatol; 2014 Nov; 23(11):858-60. PubMed ID: 25078633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain.
    Bagüés A; Martín MI; Sánchez-Robles EM
    Eur J Pharmacol; 2014 Dec; 745():69-75. PubMed ID: 25446925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inhibition of monoacylglycerol lipase by URB602 showed an anti-inflammatory and anti-nociceptive effect in a murine model of acute inflammation.
    Comelli F; Giagnoni G; Bettoni I; Colleoni M; Costa B
    Br J Pharmacol; 2007 Nov; 152(5):787-94. PubMed ID: 17700715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A unique therapeutic approach to emesis and itch with a proanthocyanidin-rich genonutrient.
    Miller MJ; Reuter BK; Wallace JL; Sharkey KA
    J Transl Med; 2008 Jan; 6():3. PubMed ID: 18205911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of peripheral mu opioid receptors in scratching behavior in mice.
    Yamamoto A; Sugimoto Y
    Eur J Pharmacol; 2010 Dec; 649(1-3):336-41. PubMed ID: 20863827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.